載入中
NASDAQHealthcareBiotechnology
最新資料
US$0.8168
+US$0.0032 · +0.39%
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
前收盤價
US$0.8168
+US$0.0032 · +0.39%
盤中時間採用ET。市場資料可能有所延遲。
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
日內區間
目前US$0.8168
52週區間
目前US$0.8168
盤中時間採用ET。市場資料可能有所延遲。
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
日內區間
目前US$0.8168
52週區間
目前US$0.8168
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 銷貨成本 | 93.6萬 USD | — | — | — | — |
| 毛利 | −93.6萬 USD | — | — | — | — |
| 研究與開發 | 2659萬 USD | 6963.7萬 USD | 8942.3萬 USD | 6803.2萬 USD | 2481.3萬 USD |
| 銷售、一般及管理費用 | 6786.4萬 USD | 7180.9萬 USD | 1653.4萬 USD | 1198.8萬 USD | 805.5萬 USD |
| 營業費用 | 9445.4萬 USD | 1.41億 USD | 1.06億 USD | 8002萬 USD | 3286.8萬 USD |
| 利息收入 | 462萬 USD | 851萬 USD | 783.3萬 USD | 277.7萬 USD | 4.9萬 USD |
| 折舊和攤銷 | 93.6萬 USD | 113.2萬 USD | 153萬 USD | 130.1萬 USD | 53.4萬 USD |
| 營業利益 | −9539萬 USD | −1.41億 USD | −1.06億 USD | −8002萬 USD | −3286.8萬 USD |
| 淨利 | −9097.3萬 USD | −2434.2萬 USD | −9721.7萬 USD | −7624.6萬 USD | −3238.5萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWC
Vanguard Health Care ETFVHTAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
